Journal article

An Interim Report of the Scleroderma Clinical Trials Consortium Working Groups.

Murray Baron, Bashar Kahaleh, Elana J Bernstein, Lorinda Chung, Philip J Clements, Christopher Denton, Robyn T Domsic, Nava Ferdowsi, Ivan Foeldvari, Tracy Frech, Jessica K Gordon, Marie Hudson, Sindhu R Johnson, Dinesh Khanna, Zsuzsannah McMahan, Peter A Merkel, Sonali Narain, Mandana Nikpour, John D Pauling, Laura Ross Show all

J Scleroderma Relat Disord | Published : 2019

Abstract

The Scleroderma Clinical Trials Consortium (SCTC) represents many of the clinical researchers in the world who are interested in improving the efficiency of clinical trials in Systemic Sclerosis (SSc). The SCTC has established 11 working groups (WGs) to develop and validate better ways of measuring and recording multiple aspects of this heterogeneous disease. These include groups working on arthritis, disease damage, disease activity, cardiac disease, juvenile SSc, the gastrointestinal tract, vascular component, calcinosis, scleroderma renal crisis, interstitial lung disease, and skin measurement. Members of the SCTC may join any one or more of these groups. Some of the WGs have only recentl..

View full abstract